Supernus Pharmaceuticals (SUPN) Shareholder's Equity (QoQ) (2012 - 2026)

Supernus Pharmaceuticals (SUPN) Shareholder's Equity (QoQ) (2012 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn
10 Supernus Pharmaceuticals 2.57 Bn 2.19 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2026 1.42%
Dec 31, 2025 1.15%
Sep 30, 2025 -1.34%
Jun 30, 2025 3.22%
Mar 31, 2025 -0.49%
Dec 31, 2024 2.84%
Sep 30, 2024 5.19%
Jun 30, 2024 3.04%
Mar 31, 2024 0.83%
Dec 31, 2023 1.02%
Sep 30, 2023 -0.84%
Jun 30, 2023 0.85%
Mar 31, 2023 2.93%
Dec 31, 2022 3.92%
Sep 30, 2022 1.35%
Jun 30, 2022 1.57%
Mar 31, 2022 1.54%
Dec 31, 2021 0.66%
Sep 30, 2021 3.17%
Jun 30, 2021 4.13%